chr22-50571172-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_152246.3(CPT1B):c.1861G>A(p.Glu621Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000805 in 1,614,030 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_152246.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CPT1B | NM_152246.3 | c.1861G>A | p.Glu621Lys | missense_variant | 15/20 | ENST00000312108.12 | NP_689452.1 | |
CHKB-CPT1B | NR_027928.2 | n.3426G>A | non_coding_transcript_exon_variant | 25/30 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CPT1B | ENST00000312108.12 | c.1861G>A | p.Glu621Lys | missense_variant | 15/20 | 1 | NM_152246.3 | ENSP00000312189 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152228Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000161 AC: 4AN: 248740Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 134644
GnomAD4 exome AF: 0.00000752 AC: 11AN: 1461802Hom.: 0 Cov.: 32 AF XY: 0.00000688 AC XY: 5AN XY: 727198
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152228Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74368
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 20, 2022 | The c.1861G>A (p.E621K) alteration is located in exon 15 (coding exon 14) of the CPT1B gene. This alteration results from a G to A substitution at nucleotide position 1861, causing the glutamic acid (E) at amino acid position 621 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at